Akanda Corp
NASDAQ:AKAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Akanda Corp
Cash & Cash Equivalents
Akanda Corp
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Akanda Corp
NASDAQ:AKAN
|
Cash & Cash Equivalents
$3.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash & Cash Equivalents
£3.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-5%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash & Cash Equivalents
$7.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
8%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash & Cash Equivalents
$217m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Cash & Cash Equivalents
£10.1m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-11%
|
|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Cash & Cash Equivalents
£32.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
13%
|
CAGR 10-Years
37%
|
|
Akanda Corp
Glance View
Akanda Corp. engages in cultivating cannabis. The firm is engaged in the cultivation, manufacturing, and distribution of cannabis. The firm cultivate and process natural cannabis at its facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower and cannabis concentrates to wholesalers in international markets. The firm also import and sell medical cannabis-based products to the domestic market in the United Kingdom. The Company’s subsidiaries include Bophelo Bio Science and Wellness (Pty) Limited, Canmart Limited, Bophelo Holdings Limited, and Cannahealth Limited. Bophelo Bio Science and Wellness (Pty) Limited is focused on the cultivation of cannabis, the production of medical cannabis products including dried flower, oils, and other concentrates. Canmart Limited is engaged in the production and sale of cannabis-based products for medicinal use.
See Also
What is Akanda Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.8m
USD
Based on the financial report for Dec 31, 2024, Akanda Corp's Cash & Cash Equivalents amounts to 3.8m USD.
What is Akanda Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
3%
Over the last year, the Cash & Cash Equivalents growth was 4 525%. The average annual Cash & Cash Equivalents growth rates for Akanda Corp have been 3% over the past three years .
